Molecular modeling of multidrug properties of resistance nodulation division (RND) transporters

Methods in Molecular Biology

Volumn 1700, Issue , 2018, Pages 179-219

  Cacciotto, Pierpaolo ^a   Ramaswamy, Venkata K ^a   Malloci, Giuliano ^a   Ruggerone, Paolo ^a   Vargiu, Attilio V ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Efflux pumps; Free energy calculations; Gram negative bacteria; Homology modeling; MD simulations; Membrane proteins; MM GBSA; Molecular docking; RND transporters

Indexed keywords

ACRB PROTEIN; MEMBRANE PROTEIN; RESISTANCE NODULATION DIVISION TRANSPORTER; UNCLASSIFIED DRUG; ACRAB-TOLC PROTEIN, E COLI; CARRIER PROTEIN; ESCHERICHIA COLI PROTEIN; MEXA PROTEIN, PSEUDOMONAS AERUGINOSA; MEXB PROTEIN, PSEUDOMONAS AERUGINOSA; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN; OPRM PROTEIN, PSEUDOMONAS AERUGINOSA; OUTER MEMBRANE PROTEIN;

COMPUTER MODEL; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOLECULAR MODEL; MOLECULAR RECOGNITION; NONHUMAN; BIOLOGY; CHEMISTRY; ESCHERICHIA COLI; METABOLISM; MULTIDRUG RESISTANCE; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PSEUDOMONAS AERUGINOSA; STRUCTURAL HOMOLOGY;

BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; COMPUTATIONAL BIOLOGY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; MEMBRANE TRANSPORT PROTEINS; MODELS, MOLECULAR; MOLECULAR DOCKING SIMULATION; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PSEUDOMONAS AERUGINOSA; STRUCTURAL HOMOLOGY, PROTEIN;

EID: 85038003691     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-7454-2_11     Document Type: Chapter

References (222)

1. Antimicrobial resistance: global report on surveillance (2014) World Health Organization.
2. Livermore DM (2004) The need for new antibiotics. Clin Microbiol Infect 10:1–9.
3. Bush K, Courvalin P, Dantas G, Davies J, Eisenstein B, Huovinen P, Jacoby GA, Kishony R, Kreiswirth BN, Kutter E, Lerner SA, Levy S, Lewis K, Lomovskaya O, Miller JH, Mobashery S, Piddock LJV, Projan S, Thomas CM, Tomasz A, Tulkens PM, Walsh TR, Watson JD, Witkowski J, Witte W, Wright G, Yeh P, Zgurskaya HI (2011) Tackling antibiotic resistance. Nat Rev Microbiol 9:894–896.
4. Bassetti M, Merelli M, Temperoni C, Astilean A (2013) New antibiotics for bad bugs: where are we? Ann Clin Microbiol Antimicrob 12:22.
5. Rex JH, Goldberger M, Eisenstein BI, Harney C (2014) The evolution of the regulatory framework for antibacterial agents. Ann N Y Acad Sci 1323:11–21.
6. Taubes G (2008) The bacteria fight back. Science 321:356–361.
7. Pitout JDD (2010) The latest threat in the war on antimicrobial resistance. Lancet Infect Dis 10(9):578.
8. Poole K, Krebes K, Mcnally C, Neshat S (1993) Multiple antibiotic-resistance in pseudomonas-aeruginosa – evidence for involvement of an efflux operon. J Bacteriol 175:7363–7372.
9. Li XM, Zolli-Juran M, Cechetto JD, Daigle DM, Wright GD, Brown ED (2004) Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibility. Chem Biol 11:1423–1430.
10. Piddock LJV (2006) Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19:382–402.
11. Nikaido H (2009) Multidrug resistance in bacteria. Annu Rev Biochem 78:119–146.
12. Poole K (2011) Pseudomonas aeruginosa: resistance to the max. Front Microbiol 2:65. https://doi.org/10.3389/fmicb.2011.00065.
13. Nikaido H, Pagès J-M (2012) Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev 36:340–363.
14. Schweizer HP (2012) Understanding efflux in Gram-negative bacteria: opportunities for drug discovery. Expert Opin Drug Discov 7:633–642.
15. Ruggerone P, Murakami S, Pos KM, Vargiu AV (2013) RND efflux pumps: structural information translated into function and inhibition mechanisms. Curr Top Med Chem 13:3079–3100.
16. Blair JMA, Richmond GE, Piddock LJV (2014) Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance. Future Microbiol 9:1165–1177.
17. Li X-Z, Plésiat P, Nikaido H (2015) The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev 28:337–418.
18. Dinh T, Paulsen IT, Saier MH (1994) A family of extracytoplasmic proteins that allow transport of large molecules across the outer membranes of Gram-negative bacteria. J Bacteriol 176:3825–3831.
19. Nikaido H (1996) Multidrug efflux pumps of gram-negative bacteria. J Bacteriol 178:5853–5859.
20. Tikhonova EB, Zgurskaya HI (2004) AcrA, AcrB, and TolC of Escherichia coli form a stable intermembrane multidrug efflux complex. J Biol Chem 279:32116–32124.
21. Lobedanz S, Bokma E, Symmons MF, Koronakis E, Hughes C, Koronakis V (2007) A periplasmic coiled-coil interface underlying ToIC recruitment and the assembly of bacterial drug eff lux pumps. Proc Natl Acad Sci U S A 104:4612–4617.
22. Symmons MF, Bokma E, Koronakis E, Hughes C, Koronakis V (2009) The assembled structure of a complete tripartite bacterial multidrug efflux pump. Proc Natl Acad Sci U S A 106:7173–7178.
23. Pos KM (2009) Trinity revealed: stoichiometric complex assembly of a bacterial multidrug efflux pump. Proc Natl Acad Sci U S A 106:6893–6894.
24. Su CC, Long F, Zimmermann MT, Rajashankar KR, Jernigan RL, Yu EW (2011) Crystal structure of the CusBA heavy-metal efflux complex of Escherichia coli. Nature 470:558–562.
25. Du D, Wang Z, James NR, Voss JE, Klimont E, Ohene-Agyei T, Venter H, Chiu W, Luisi BF (2014) Structure of the AcrAB-TolC multidrug efflux pump. Nature 509:512–515.
26. Jin-Sik K, Hyeongseop J, Saemee S, Hye-Yeon K, Kangseok L, Jaekyung H, And Nam-Chul H (2015) Structure of the tripartite multidrug efflux pump AcrAB-TolC suggests an alternative assembly mode. Mol Cells 38:180–186.
27. Zgurskaya HI, Weeks JW, Ntreh AT, Nickels LM, Wolloscheck D (2015) Mechanism of coupling drug transport reactions located in two different membranes. Front Microbiol 6:100.
28. Du D, Van Veen HW, Luisi BF (2015) Assembly and operation of bacterial tripartite multidrug efflux pumps. Trends Microbiol 23:311–319.
29. Zgurskaya HI, Nikaido H (1999) Bypassing the periplasm: reconstitution of the AcrAB multidrug efflux pump of Escherichia coli. Proc Natl Acad Sci U S A 96:7190–7195.
30. Murakami S, Nakashima R, Yamashita E, Yamaguchi A (2002) Crystal structure of bacterial multidrug efflux transporter AcrB. Nature 419:587–593.
31. Murakami S, Nakashima R, Yamashita E, Matsumoto T, Yamaguchi A (2006) Crystal structures of a multidrug transporter reveal a functionally rotating mechanism. Nature 443:173–179.
32. Seeger MA, Schiefner A, Eicher T, Verrey F, Diederichs K, Pos KM (2006) Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism. Science 313:1295–1298.
33. Sennhauser G, Amstutz P, Briand C, Storchenegger O, Grutter MG (2007) Drug export pathway of multidrug exporter AcrB revealed by DARPin inhibitors. PLoS Biol 5:106–113.
34. Sennhauser G, Bukowska MA, Briand C, Grutter MG (2009) Crystal structure of the multidrug exporter MexB from Pseudomonas aeruginosa. J Mol Biol 389:134–145.
35. Mazzariol A, Cornaglia G, Nikaido H (2000) Contributions of the AmpC beta-lactamase and the AcrAB multidrug efflux system in intrinsic resistance of Escherichia coli K-12 to beta-lactams. Antimicrob Agents Chemother 44:1387–1390.
36. Elkins CA, Nikaido H (2002) Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominately by two large periplasmic loops. J Bacteriol 184:6490–6498.
37. Baucheron S, Imberechts H, Chaslus-Dancla E, Cloeckaert A (2002) The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in salmonella enterica serovar typhimurium phage type DT204. Microb Drug Resist 8:281–289.
38. Middlemiss JK, Poole K (2004) Differential impact of MexB mutations on substrate selectivity of the MexAB-OprM multidrug efflux pump of Pseudomonas aeruginosa. J Bacteriol 186:1258–1269.
39. Kinana AD, Vargiu AV, Nikaido H (2013) Some ligands enhance the efflux of other ligands by the Escherichia coli multidrug pump AcrB. Biochemistry 52:8342–8351.
40. Kobayashi N, Tamura N, Van Veen HW, Yamaguchi A, Murakami S (2014) ß-Lactam selectivity of multidrug transporters AcrB and AcrD resides in the proximal binding pocket. J Biol Chem 289:10680–10690.
41. Koronakis V, Sharff A, Koronakis E, Luisi B, Hughes C (2000) Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 405:914–919.
42. Higgins MK, Eswaran J, Edwards P, Schertler GFX, Hughes C, Koronakis V (2004) Structure of the ligand-blocked periplasmic entrance of the bacterial multidrug efflux protein TolC. J Mol Biol 342:697–702.
43. Phan G, Benabdelhak H, Lascombe MB, Benas P, Rety S, Picard M, Ducruix A, Etchebest C, Broutin I (2010) Structural and dynamical insights into the opening mechanism of P. aeruginosa OprM channel. Structure 18:507–517.
44. Akama H, Kanemaki M, Yoshimura M, Tsukihara T, Kashiwagi T, Yoneyama H, Narita S, Nakagawa A, Nakae T (2004) Crystal structure of the drug discharge outer membrane protein, OprM, of Pseudomonas aeruginosa – dual modes of membrane anchoring and occluded cavity end. J Biol Chem 279:52816–52819.
45. Bavro VN, Pietras Z, Furnham N, Perez-Cano L, Fernandez-Recio J, Pei XY, Misra R, Luisi B (2008) Assembly and channel opening in a bacterial drug efflux machine. Mol Cell 30:114–121.
46. Poole K (2001) Multidrug resistance in Gram-negative bacteria. Curr Opin Microbiol 4:500–508.
47. Akama H, Matsuura T, Kashiwagi S, Yoneyama H, Narita SI, Tsukihara T, Nakagawa A, Nakae T (2004) Crystal structure of the membrane fusion protein, MexA, of the multidrug transporter in Pseudomonas aeruginosa. J Biol Chem 279:25939–25942.
48. Higgins MK, Bokma E, Koronakis E, Hughes C, Koronakis V (2004) Structure of the periplasmic component of a bacterial drug efflux pump. Proc Natl Acad Sci U S A 101:9994–9999.
49. Mikolosko J, Bobyk K, Zgurskaya HI, Ghosh P (2006) Conformational flexibility in the multidrug efflux system protein AcrA. Structure 14:577–587.
50. Xu Y, Lee M, Moeller A, Song S, Yoon B-Y, Kim H-M, Jun S-Y, Lee K, Ha N-C (2011) Funnel-like hexameric assembly of the periplasmic adapter protein in the tripartite multidrug efflux pump in Gram-negative bacteria. J Biol Chem 286:17910–17920.
51. Hobbs EC, Yin X, Paul BJ, Astarita JL, Storz G (2012) Conserved small protein associates with the multidrug efflux pump AcrB and differentially affects antibiotic resistance. Proc Natl Acad Sci U S A 109:16696–16701.
52. Elkins CA, Nikaido H (2003) Chimeric analysis of AcrA function reveals the importance of its c-terminal domain in its interaction with the AcrB multidrug efflux pump. J Bacteriol 185:5349–5356.
53. Elkins CA, Nikaido H (2003) 3D structure of AcrB: the archetypal multidrug efflux transporter of Escherichia coli likely captures substrates from periplasm. Drug Resist Updat 6:9–13.
54. Trépout S, Taveau J-C, Benabdelhak H, Granier T, Ducruix A, Frangakis AS, Lambert O (2010) Structure of reconstituted bacterial membrane efflux pump by cryo-electron tomography. BBA-Biomembranes 1798:1953–1960.
55. Nakashima R, Sakurai K, Yamasaki S, Nishino K, Yamaguchi A (2011) Structures of the multidrug exporter AcrB reveal a proximal multisite drug-binding pocket. Nature 480:565–569.
56. Pei X-Y, Hinchliffe P, Symmons MF, Koronakis E, Benz R, Hughes C, Koronakis V (2011) Structures of sequential open states in a symmetrical opening transition of the TolC exit duct. Proc Natl Acad Sci U S A 108:2112–2117.
57. Xu Y, Moeller A, Jun S-Y, Le M, Yoon B-Y, Kim J-S, Lee K, Ha N-C (2012) Assembly and channel opening of outer membrane protein in tripartite drug efflux pumps of Gram-negative bacteria. J Biol Chem 287:11740–11750.
58. Hinchliffe P, Symmons MF, Hughes C, Koronakis V (2013) Structure and operation of bacterial tripartite pumps. Annu Rev Microbiol 67(67):221–242.
59. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739–1749.
60. Nissink JWM, Murray C, Hartshorn M, Verdonk ML, Cole JC, Taylor R (2002) A new test set for validating predictions of protein-ligand interaction. Proteins 49:457–471.
61. Jorgensen WL (2004) The many roles of computation in drug discovery. Science 303:1813–1818.
62. Van Gunsteren WF, Bakowies D, Baron R, Chandrasekhar I, Christen M, Daura X, Gee P, Geerke DP, Glattli A, Hunenberger PH, Kastenholz MA, Ostenbrink C, Schenk M, Trzesniak D, Van Der Vegt NFA, Yu HB (2006) Biomolecular modeling: goals, problems, perspectives. Angew Chem Int Ed 45:4064–4092.
63. Dodson GG, Lane DP, Verma CS (2008) Molecular simulations of protein dynamics: new windows on mechanisms in biology. EMBO Rep 9:144–150.
64. Lee EH, Hsin J, Sotomayor M, Comellas G, Schulten K (2009) Discovery through the computational microscope. Structure 17:1295–1306.
65. Trott O, Olson AJ (2010) Autodock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–461.
66. De Vries SJ, Zacharias M (2012) ATTRACT-EM: a new method for the computational assembly of large molecular machines using cryo-EM maps. PLoS One 7:e49733.
67. Karplus M, Lavery R (2014) Significance of molecular dynamics simulations for life sciences. Isr J Chem 54:1042–1051.
68. Dror RO, Dirks RM, Grossman JP, Xu HF, Shaw DE (2012) Biomolecular simulation: a computational microscope for molecular biology. Annu Rev Biophys 41:429–452.
69. Ruiz-Carmona S, Alvarez-Garcia D, Foloppe N, Garmendia-Doval AB, Juhos S, Schmidtke P, Barril X, Hubbard RE, Morley SD (2014) rDock: a fast, versatile and open source program for docking ligands to proteins and nucleic acids. PLoS Comput Biol 10:e1003571.
70. Gilson MK, Zhou HX (2007) Calculation of protein-ligand binding affinities. Annu Rev Biophys Biomol Struct 36:21–42.
71. Mortier J, Rakers C, Bermudez M, Murgueitio MS, Riniker S, Wolber G (2015) The impact of molecular dynamics on drug design: applications for the characterization of ligand-macromolecule complexes. Drug Discov Today 20:686–702.
72. Shaw DE, Deneroff MM, Dror RO, Kuskin JS, Larson RH, Salmon JK, Young C, Batson B, Bowers KJ, Chao JC, Eastwood MP, Gagliardo J, Grossman JP, Ho CR, Ierardi DJ, Kolossvary I, Klepeis JL, Layman T, Mcleavey C, Moraes MA, Mueller R, Priest EC, Shan YB, Spengler J, Theobald M, Towles B, Wang SC (2008) Anton, a special-purpose machine for molecular dynamics simulation. Commun ACM 51:91–97.
73. Anderson JA, Lorenz CD, Travesset A (2008) General purpose molecular dynamics simulations fully implemented on graphics processing units. J Comput Phys 227:5342–5359.
74. Harvey MJ, Giupponi G, Fabritiis GD (2009) ACEMD: accelerating biomolecular dynamics in the microsecond time scale. J Chem Theory Comput 5:1632–1639.
75. Le Grand S, Gotz AW, Walker RC (2013) SPFP: speed without compromise—a mixed precision model for GPU accelerated molecular dynamics simulations. Comput Phys Commun 184:374–380.
76. Ruggerone P, Vargiu AV, Collu F, Fischer N, Kandt C (2013) Molecular dynamics computer simulations of multidrug RND efflux pumps. Comput Struct Biotechnol J 5:e201302008.
77. Schulz R, Vargiu AV, Collu F, Kleinekathofer U, Ruggerone P (2010) Functional rotation of the transporter AcrB: insights into drug extrusion from simulations. PLoS Comput Biol 6:e1000806.
78. Schulz R, Vargiu AV, Ruggerone P, Kleinekathofer U (2011) Role of water during the extrusion of substrates by the efflux transporter AcrB. J Phys Chem B 115:8278–8287.
79. Vargiu AV, Collu F, Schulz R, Pos KM, Zacharias M, KleinekathöFer U, Ruggerone P (2011) Effect of the F610A mutation on substrate extrusion in the AcrB transporter: explanation and rationale by molecular dynamics simulations. J Am Chem Soc 133:10704–10707.
80. Collu F, Vargiu AV, Dreier J, Cascella M, Ruggerone P (2012) Recognition of imipenem and meropenem by the RND-transporter MexB studied by computer simulations. J Am Chem Soc 134:19146–19158.
81. Vargiu AV, Nikaido H (2012) Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations. Proc Natl Acad Sci U S A 109:20637–20642.
82. Vargiu AV, Ruggerone P, Opperman TJ, Nguyen ST, Nikaido H (2014) Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitors. Antimicrob Agents Chemother 58:6224–6234.
83. Blair JMA, Bavro VN, Ricci V, Modi N, Cacciotto P, Kleinekathoefer U, Ruggerone P, Vargiu AV, Baylay AJ, Smith HE, Brandon Y, Galloway D, Piddock LJV (2015) AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity. Proc Natl Acad Sci U S A 112:3511–3516.
84. Schulz R, Vargiu AV, Ruggerone P, Kleinekathoefer U (2015) Computational study of correlated domain motions in the AcrB efflux transporter. Biomed Res Int 2015:487298.
85. Kinana AD, Vargiu AV, May T, Nikaido H (2016) Aminoacyl ß-naphthylamides as substrates and modulators of AcrB multidrug efflux pump. Proc Natl Acad Sci U S A 113:1405–1410.
86. Sjuts H, Vargiu AV, Kwasny SM, Nguyen ST, Kim H-S, Ding X, Ornik AR, Ruggerone P, Bowlin TL, Nikaido H, Pos KM, Opperman TJ (2016) Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives. Proc Natl Acad Sci U S A 113:3509–3514.
87. Fischer N, Kandt C (2011) Three ways in, one way out: water dynamics in the trans-membrane domains of the inner membrane translocase AcrB. Proteins 79:2871–2885.
88. Fischer N, Kandt C (2013) Porter domain opening and closing motions in the multi-drug efflux transporter AcrB. BBA-Biomembranes 1828:632–641.
89. Fischer N, Raunest M, Schmidt TH, Koch DC, Kandt C (2014) Efflux pump-mediated antibiotics resistance: insights from computational structural biology. Interdiscip Sci 6:1–12.
90. Koch DC, Raunest M, Harder T, Kandt C (2013) Unilateral access regulation: ground state dynamics of the Pseudomonas aeruginosa outer membrane efflux duct OprM. Biochemistry 52:178–187.
91. Raunest M, Kandt C (2012) Locked on one side only: ground state dynamics of the outer membrane efflux duct TolC. Biochemistry 51:1719–1729.
92. Yamane T, Murakami S, Ikeguchi M (2013) Functional rotation induced by alternating protonation states in the multidrug transporter AcrB: all-atom molecular dynamics simulations. Biochemistry 52:7648–7658.
93. Wang B, Weng J, Wang W (2015) Substrate binding accelerates the conformational transitions and substrate dissociation in multidrug efflux transporter AcrB. Front Microbiol 6:302.
94. Vaccaro L, Koronakis V, Sansom MSP (2006) Flexibility in a drug transport accessory protein: molecular dynamics simulations of MexA. Biophys J 91:558–564.
95. Vaccaro L, Scott KA, Sansom MSP (2008) Gating at both ends and breathing in the middle: conformational dynamics of TolC. Biophys J 95:5681–5691.
96. Wang B, Weng J, Fan K, Wang W (2012) Interdomain flexibility and pH-induced conformational changes of AcrA revealed by molecular dynamics simulations. J Phys Chem B 116:3411–3420.
97. Yamaguchi A, Nakashima R, Sakurai K (2015) Structural basis of RND-type multidrug exporters. Front Microbiol 6:327.
98. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779–815.
99. Bower MJ, Cohen FE, Dunbrack RL (1997) Prediction of protein side-chain rotamers from a backbone-dependent rotamer library: a new homology modeling tool. J Mol Biol 267:1268–1282.
100. Marti-Renom MA, Stuart AC, Fiser A, Sanchez R, Melo F, Sali A (2000) Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 29:291–325.
101. Schwede T, Kopp J, Guex N, Peitsch MC (2003) SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res 31:3381–3385.
102. Šali A, Potterton L, Yuan F, Van Vlijmen H, Karplus M (1995) Evaluation of comparative protein modeling by MODELLER. Proteins 23:318–326.
103. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen M-Y, Pieper U, Sali A (2006) Comparative protein structure modeling using modeller. Curr Protoc Bioinformatics 15:5.6:5.6.1–5.6.30.
104. Sali A, Overington JP (1994) Derivation of rules for comparative protein modeling from a database of protein structure alignments. Protein Sci 3:1582–1596.
105. Webb B, Sali A (2014) Comparative protein structure modeling using MODELLER. Curr Protoc Bioinformatics 47:5.6:5.6.1–5.6.32.
106. Sousa SF, Fernandes PA, Ramos MJ (2006) Protein-ligand docking: current status and future challenges. Proteins 65:15–26.
107. Rodrigues JP, Karaca E, Bonvin AM (2015) Information-driven structural modelling of protein-protein interactions. Methods Mol Biol 1215:399–424.
108. Chen YC (2015) Beware of docking Trends Pharmacol Sci 36:78–95.
109. Amaro RE, Baron R, Mccammon JA (2008) An improved relaxed complex scheme for receptor flexibility in computer-aided drug design. J Comput Aided Mol Des 22:693–705.
110. Huang S-Y, Zou X (2007) Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking. Proteins 66:399–421.
111. Takatsuka Y, Chen C, Nikaido H (2010) Mechanism of recognition of compounds of diverse structures by the multidrug efflux pump AcrB of Escherichia coli. Proc Natl Acad Sci U S A 107:6559–6565.
112. Karplus M, Mccammon JA (2002) Molecular dynamics simulations of biomolecules. Nat Struct Biol 9:646–652.
113. Van Gunsteren WF, Billeter SR, Eising AA, Hunenberger PH, Kruger P, Mark AE, Scott WRP, Tironi IG (1996) Biomolecular simulation: the GROMOS96 manual and user guide. Hochschulverlag AG an der ETH, Zurich.
114. Jorgensen WL, Tirado-Rives J (1988) The OPLS force field for proteins. Energy minimizations for crystals of cyclic peptides and crambin. J Am Chem Soc 110:1657–1666.
115. Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25:1157–1174.
116. Brooks BR, Brooks CL 3rd, Mackerell AD Jr, Nilsson L, Petrella RJ, Roux B, Won Y, Archontis G, Bartels C, Boresch S, Caflisch A, Caves L, Cui Q, Dinner AR, Feig M, Fischer S, Gao J, Hodoscek M, Im W, Kuczera K, Lazaridis T, Ma J, Ovchinnikov V, Paci E, Pastor RW, Post CB, Pu JZ, Schaefer M, Tidor B, Venable RM, Woodcock HL, Wu X, Yang W, York DM, Karplus M (2009) CHARMM: the biomolecular simulation program. J Comput Chem 30:1545–1614.
117. Ponder JW, Case DA (2003) Force fields for protein simulations. Adv Protein Chem 66:27–85.
118. Halgren TA, Damm W (2001) Polarizable force fields. Curr Opin Struct Biol 11:236–242.
119. Graen T, Hoefling M, Grubmuller H (2014) AMBER-DYES: characterization of charge fluctuations and force field parameterization of fluorescent dyes for molecular dynamics simulations. J Chem Theory Comput 10:5505–5512.
120. Malde AK, Zuo L, Breeze M, Stroet M, Poger D, Nair PC, Oostenbrink C, Mark AE (2011) An automated force field topology builder (ATB) and repository: version 1.0. J Chem Theory Comput 7:4026–4037.
121. Vanquelef E, Simon S, Marquant G, Garcia E, Klimerak G, Delepine JC, Cieplak P, Dupradeau FY (2011) R.E.D. Server: a web service for deriving RESP and ESP charges and building force field libraries for new molecules and molecular fragments. Nucleic Acids Res 39:W511–W517.
122. Mayne CG, Saam J, Schulten K, Tajkhorshid E, Gumbart JC (2013) Rapid parameterization of small molecules using the force field toolkit. J Comput Chem 34:2757–2770.
123. Marvin, Marvin 14.8.25.0 (2012) http://www.chemaxon.com.
124. Case DA, Berryman JT, Betz RM, Cerutti DS, Cheatham Iii TE, Darden TA, Duke RE, Giese TJ, Gohlke H, Goetz AW, Homeyer N, Izadi S, Janowski P, Kaus J, Kovalenko A, Lee TS, Legrand S, Li P, Luchko T, Luo R, Madej B, Merz KM, Monard G, Needham P, Nguyen H, Nguyen HT, Omelyan I, Onufriev A, Roe DR, Roitberg A, Salomon-Ferrer R, Simmerling CL, Smith W, Swails J, Walker RC, Wang J, Wolf RM, Wu X, York DM, Kollman PA (2015) AMBER 2015. University of California, San Francisco.
125. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T Jr, Montgomery JA, Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam JM, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas Ö, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ (2009) Gaussian 09, Revision A.1. Gaussian, Inc., Wallingford, CT.
126. Klauda JB, Venable RM, Freites JA, O’connor JW, Tobias DJ, Mondragon-Ramirez C, Vorobyov I, Mackerell AD Jr, Pastor RW (2010) Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types. J Phys Chem B 114:7830–7843.
127. Central.
128. Dickson CJ, Madej BD, Skjevik AA, Betz RM, Teigen K, Gould IR, Walker RC (2014) Lipid14: the amber lipid force field. J Chem Theory Comput 10:865–879.
129. Central.
130. Poger D, Van Gunsteren WF, Mark AE (2010) A new force field for simulating phosphatidylcholine bilayers. J Comput Chem 31:1117–1125.
131. Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, Simmerling C (2006) Comparison of multiple amber force fields and development of improved protein backbone parameters. Proteins 65:712–725.
132. Central.
133. Malloci G, Vargiu A, Serra G, Bosin A, Ruggerone P, Ceccarelli M (2015) A database of force-field parameters, dynamics, and properties of antimicrobial compounds. Molecules 20:13997.
134. Malloci G, Serra G, Bosin A, Vargiu AV (2016) Extracting conformational ensembles of small molecules from molecular dynamics simulations: ampicillin as a test case. Computation 4:5.
135. Stavenger RA, Winterhalter M (2014) TRANSLOCATION project: how to get good drugs into bad bugs. Sci Transl Med 6:228ed7.
136. Van Meer G, Voelker DR, Feigenson GW (2008) Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 9:112–124.
137. Tieleman DP, Marrink SJ, Berendsen HJ (1997) A computer perspective of membranes: molecular dynamics studies of lipid bilayer systems. Biochim Biophys Acta 1331:235–270.
138. Berger O, Edholm O, Jahnig F (1997) Molecular dynamics simulations of a fluid bilayer of dipalmitoylphosphatidylcholine at full hydration, constant pressure, and constant temperature. Biophys J 72:2002–2013.
139. Marrink SJ, Risselada HJ, Yefimov S, Tieleman DP, De Vries AH (2007) The MARTINI force field: coarse grained model for biomolecular simulations. J Phys Chem B 111:7812–7824.
140. Orsi M, Essex JW (2011) The ELBA force field for coarse-grain modeling of lipid membranes. PLoS One 6:e28637.
141. Marrink SJ, Tieleman DP (2013) Perspective on the Martini model. Chem Soc Rev 42:6801–6822.
142. Cheatham TE 3rd, Case DA (2013) Twenty-five years of nucleic acid simulations. Biopolymers 99:969–977.
143. Vargiu AV, Magistrato A (2014) Atomistic-level portrayal of drug-DNA interplay: a history of courtships and meetings revealed by molecular simulations. ChemMedChem 9:1966–1981.
144. Perez A, Marchan I, Svozil D, Sponer J, Cheatham TE 3rd, Laughton CA, Orozco M (2007) Refinement of the AMBER force field for nucleic acids: improving the description of {alpha}/{gamma} conformers. Biophys J 92:3817–3829.
145. Soares TA, Hünenberger PH, Kastenholz MA, Kräutler V, Lenz T, Lins RD, Oostenbrink C, Van Gunsteren WF (2005) An improved nucleic acid parameter set for the GROMOS force field. J Comput Chem 26:725–737.
146. Mackerell AD, Bashford D, Bellott M, Dunbrack RL, Evanseck JD, Field MJ, Fischer S, Gao J, Guo H, Ha S, Joseph-Mccarthy D, Kuchnir L, Kuczera K, Lau FT, Mattos C, Michnick S, Ngo T, Nguyen DT, Prodhom B, Reiher WE, Roux B, Schlenkrich M, Smith JC, Stote R, Straub J, Watanabe M, Wiorkiewicz-Kuczera J, Yin D, Karplus M (1998) All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 102:3586–3616.
147. Siu SWI, Vácha R, Jungwirth P, Böckmann RA (2008) Biomolecular simulations of membranes : physical properties from different force fields. J Chem Phys 128:125103.
148. Marrink SJ, De Vries AH, Tieleman DP (2009) Lipids on the move: simulations of membrane pores, domains, stalks and curves. Biochim Biophys Acta 1788:149–168.
149. Lyubartsev AP, Rabinovich AL (2011) Recent development in computer simulations of lipid bilayers. Soft Matter 7:25–39.
150. Leftin A, Brown MF (2011) An NMR database for simulations of membrane dynamics. Biochim Biophys Acta 1808:818–839.
151. Bennett WF, Tieleman DP (2013) Computer simulations of lipid membrane domains. Biochim Biophys Acta 1828:1765–1776.
152. Chavent M, Reddy T, Goose J, Dahl AC, Stone JE, Jobard B, Sansom MS (2014) Methodologies for the analysis of instantaneous lipid diffusion in MD simulations of large membrane systems. Faraday Discuss 169:455–475.
153. Javanainen M (2014) Universal method for embedding proteins into complex lipid bilayers for molecular dynamics simulations. J Chem Theory Comput 10:2577–2582.
154. Schmidt TH, Kandt C (2012) LAMBADA and InflateGRO2: efficient membrane alignment and insertion of membrane proteins for molecular dynamics simulations. J Chem Inf Model 52:2657–2669.
155. Balabin IA (2010) Membrane Plug-in.
156. Guixa-Gonzalez R, Rodriguez-Espigares I, Ramirez-Anguita JM, Carrio-Gaspar P, Martinez-Seara H, Giorgino T, Selent J (2014) MEMBPLUGIN: studying membrane complexity in VMD. Bioinformatics 30:1478–1480.
157. Nagle JF, Tristram-Nagle S (2000) Lipid bilayer structure. Curr Opin Struct Biol 10:474–480.
158. Lis LJ, Mcalister M, Fuller N, Rand RP, Parsegian VA (1982) Interactions between neutral phospholipid bilayer membranes. Biophys J 37:657–665.
159. Rand RP, Parsegian VA (1989) Hydration forces between phospholipid bilayers. Biochem Biophys Acta 988:351–376.
160. Zimmerberg J (1987) Molecular mechanisms of membrane fusion: steps during phospholipid and exocytotic membrane fusion. Biosci Rep 7:251–268.
161. Rand RP. Structural parameters of aqueous phospholipid mixtures. Available from: https://brocku.ca/researchers/peter_rand/lipid/.
162. Kucerka N, Katsaras J, Nagle JF (2010) Comparing membrane simulations to scattering experiments: introducing the SIMtoEXP software. J Membr Biol 235:43–50.
163. Skjevik AA, Madej BD, Walker RC, Teigen K (2012) LIPID11: a modular framework for LIPID simulations using amber. J Phys Chem B 116(36):11124.
164. Allen WJ, Lemkul JA, Bevan DR (2009) GridMAT-MD: a grid-based membrane analysis tool for use with molecular dynamics. J Comput Chem 30:1952–1958.
165. Dickson CJ, Rosso L, Betz RM, Walker RC, Gould IR (2012) GAFFlipid: a general amber force field for the accurate molecular dynamics simulation of phospholipid. Soft Matter 8:9617–9627.
166. Shinoda W, Okazaki S (1998) A Voronoi analysis of lipid area fluctuation in a bilayer. J Chem Phys 109:1517–1521.
167. Mori T, Ogushi F, Sugita Y (2012) Analysis of lipid surface area in protein-membrane systems combining Voronoi tessellation and Monte Carlo integration methods. J Comput Chem 33:286–293.
168. Gapsys V, De Groot BL, Briones R (2013) Computational analysis of local membrane properties. J Comput Aided Mol Des 27:845–858.
169. Gilson MK, Given JA, Bush BL, Mccammon JA (1997) The statistical-thermodynamic basis for computation of binding affinities: a critical review. Biophys J 72:1047–1069.
170. Woo HJ, Roux B (2005) Calculation of absolute protein-ligand binding free energy from computer simulations. Proc Natl Acad Sci U S A 102:6825–6830.
171. Jiao D, Golubkov PA, Darden TA, Ren P (2008) Calculation of protein-ligand binding free energy by using a polarizable potential. Proc Natl Acad Sci U S A 105:6290–6295.
172. Mitomo D, Fukunishi Y, Higo J, Nakamura H (2009) Calculation of protein-ligand binding free energy using smooth reaction path generation (SRPG) method: a comparison of the explicit water model, gb/sa model and docking score function. Genome Inform 23:85–97.
173. Steinbrecher T, Labahn A (2010) Towards accurate free energy calculations in ligand protein-binding studies. Curr Med Chem 17:767–785.
174. Rathore RS, Sumakanth M, Reddy MS, Reddanna P, Rao AA, Erion MD, Reddy MR (2013) Advances in binding free energies calculations: QM/MM-based free energy perturbation method for drug design. Curr Pharm Des 19:4674–4686.
175. Srinivasan J, Cheatham Iii TE, Cieplak P, Kollman PA, Case DA (1998) Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate-DNA helices. J Am Chem Soc 120:9401–9409.
176. Kollman PA, Massova I, Reyes C, Kuhn B, Huo SH, Chong L, Lee M, Lee T, Duan Y, Wang W, Donini O, Cieplak P, Srinivasan J, Case DA, Cheatham TE (2000) Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res 33:889–897.
177. Fogolari F, Brigo A, Molinari H (2003) Protocol for MM/PBSA molecular dynamics simulations of proteins. Biophys J 85:159–166.
178. Hou T, Wang J, Li Y, Wang W (2010) Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model 51:69–82.
179. Kongsted J, Ryde U (2009) An improved method to predict the entropy term with the MM/PBSA approach. J Comput Aided Mol Des 23:63–71.
180. Massova I, Kollman PA (1999) Computational alanine scanning to probe protein-protein interactions: a novel approach to evaluate binding free energies. J Am Chem Soc 121:8133–8143.
181. Fiser A, Do RKG, Sali A (2000) Modeling of loops in protein structures. Protein Sci 9:1753–1773.
182. Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14:33–38.
183. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215:403–410.
184. Gish W, States DJ (1993) Identification of protein coding regions by database similarity search. Nat Genet 3:266–272.
185. Madden TL, Tatusov RL, Zhang J (1996) Applications of network BLAST server. Methods Enzymol 266:131–141.
186. Shen MY, Sali A (2006) Statistical potential for assessment and prediction of protein structures. Protein Sci 15:2507–2524.
187. Bolton EE, Wang Y, Thiessen PA, Bryant SH (2008) PubChem: integrated platform of small molecules and biological activities. In: Wheeler RA, Spellmeyer DC (eds) Annual reports in computational chemistry. Elsevier, Oxford, pp 217–241.
188. O’boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open babel: an open chemical toolbox. J Cheminform 3:33.
189. Hohenberg P, Kohn W (1964) Inhomogeneous electron gas. Phys Rev 136:B864–B871.
190. Kohn W, Sham L (1965) Self-consistent equations including exchange and correlation effects. Phys Rev 140:A1133–A1138.
191. Becke AD (1993) Density-functional thermochemistry. 3. The role of exact exchange. J Chem Phys 98:5648–5652.
192. Kim K, Jordan KD (1994) Comparison of density-functional and Mp2 calculations on the water monomer and dimer. J Phys Chem 98:10089–10094.
193. Pople JA (1999) Quantum chemical models (Nobel lecture). Angew Chem Int Ed 38:1894–1902.
194. Tomasi J, Mennucci B, Cammi R (2005) Quantum mechanical continuum solvation models. Chem Rev 105:2999–3093.
195. Singh UC, Kollman PA (1984) An approach to computing electrostatic charges for molecules. J Comput Chem 5:129–145.
196. Laio A, Vandevondele J, Rothlisberger U (2002) D-RESP : dynamically generated electrostatic potential derived charges from quantum mechanics/molecular mechanics simulations. J Phys Chem B 106:7300–7307.
197. Wang J, Wang W, Kollman PA, Case DA (2006) Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model 25:247–260.
198. Dolinsky TJ, Nielsen JE, Mccammon JA, Baker NA (2004) PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res 32:W665–W667.
199. Schuttelkopf AW, Van Aalten DM (2004) PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr 60:1355–1363.
200. Kandasamy SK, Larson RG (2006) Molecular dynamics simulations of model trans-membrane peptides in lipid bilayers: a systematic investigation of hydrophobic mismatch. Biophys J 90:2326–2343.
201. Lindahl E, Sansom MSP (2008) Membrane proteins : molecular dynamics simulations. Curr Opin Struct Biol 18:425–431.
202. Gurtovenko AA, Vattulainen I (2009) Calculation of the electrostatic potential of lipid bilayers from molecular dynamics simulations: methodological issues. J Chem Phys 130:215107.
203. Stansfeld PJ, Sansom MS (2011) Molecular simulation approaches to membrane proteins. Structure 19:1562–1572.
204. Jo S, Kim T, Iyer VG, Im W (2008) CHARMM-GUI: a web-based graphical user interface for CHARMM. J Comput Chem 29:1859–1865.
205. Wu EL, Cheng X, Jo S, Rui H, Song KC, Davila-Contreras EM, Qi Y, Lee J, Monje-Galvan V, Venable RM, Klauda JB, Im W (2014) CHARMM-GUI membrane builder toward realistic biological membrane simulations. J Comput Chem 35:1997–2004.
206. Lomize MA, Pogozheva ID, Joo H, Mosberg HI, Lomize AL (2012) OPM database and PPM web server: resources for positioning of proteins in membranes. Nucleic Acids Res 40:D370–D376.
207. Kimmett T, Smith N, Witham S, Petukh M, Sarkar S, Alexov E (2014) ProBLM web server: protein and membrane placement and orientation package. Comput Math Methods Med 2014:838259.
208. Kufareva I, Lenoir M, Dancea F, Sridhar P, Raush E, Bissig C, Gruenberg J, Abagyan R, Overduin M (2014) Discovery of novel membrane binding structures and functions. Biochem Cell Biol 92:555–563.
209. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926–935.
210. Joung IS, Cheatham TE (2008) Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations. J Phys Chem B 112:9020–9041.
211. Pearlman DA, Case DA, Caldwell JW, Ross WS, Cheatham Iii TE, Debolt S, Ferguson D, Seibel G, Kollman P (1995) AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Comput Phys Commun 91:1–41.
212. Wimberly BT, Guymon R, Mccutcheon JP, White SW, Ramakrishnan V (1999) A detailed view of a ribosomal active site: the structure of the L11-RNA complex. Cell 97:491–502.
213. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kale L, Schulten K (2005) Scalable molecular dynamics with NAMD. J Comput Chem 26:1781–1802.
214. Pronk S, Pall S, Schulz R, Larsson P, Bjelkmar P, Apostolov R, Shirts MR, Smith JC, Kasson PM, Van Der Spoel D, Hess B, Lindahl E (2013) GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29:845–854.
215. Miller BR, Mcgee TD, Swails JM, Homeyer N, Gohlke H, Roitberg AE (2012) MMPBSA.py: an efficient program for end-state free energy calculations. J Chem Theory Comput 8:3314–3321.
216. Tsui V, Case DA (2000) Molecular dynamics simulations of nucleic acids with a generalized born solvation model. J Am Chem Soc 122:2489–2498.
217. Bondi A (1964) van der Waals Volumes and Radii. J Phys Chem 68:441–451.
218. Onufriev A, Bashford D, Case DA (2004) Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins 55:383–394.
219. Mongan J, Simmerling C, Mccammon JA, Case DA, Onufriev A (2007) Generalized Born model with a simple, robust molecular volume correction. J Chem Theory Comput 3:156–169.
220. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785–2791.
221. Grossfield A, Zuckerman DM (2009) Quantifying uncertainty and sampling quality in biomolecular simulations. Annu Rep Comput Chem 5:23–48.
222. Grossfield A, Feller SE, Pitman MC (2007) Convergence of molecular dynamics simulations of membrane proteins. Proteins 40:31–40.